| 摘要 |
<p>Simultaneously using both a non-FP receptor agonist type prostaglandin compound (such as isopropyl unoprostone) and an FP receptor agonist type prostaglandin compound (such as latanoprost) brings about a synergistically enhanced ocular tension lowering effect.</p> |
